Drugs / MCV4-TT
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03205358 Comparator | Mar → Aug 2015 | meningococcal meningitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MCV4-TT | “versus a licensed conjugate vaccine MCV4-TT (NCT03205358)” PMID 32233959 ↗ Apr 2020 |
| Modality | Vaccine | “licensed conjugate vaccine MCV4-TT” PMID 32233959 ↗ Apr 2020 |
| Route | Intramuscular | “0.5 mL, IM” NCT03205358 ↗ |